Skip to content

Cresco Labs Inc.

CRLBF· OTCCore metricsCIK 1832928

Medicinal chemicals & botanical products40 peers

Close
Oct 27, 2026 · -1.61%
Market cap
—
no share count on file
Filings
94
$655.85M
FY 2025−9.5% FY25 yoy
-$135.41M
FY 2025N/M FY25 yoy
-$27.99M
FY 2025N/M FY25 yoy
$37.75M
FY 2025derived−66.6% FY25 yoy
-$0.38
FY 2025N/M FY25 yoy
$57.90M
FY 2025−57.9% FY25 yoy

Price

$0.6149.17%$0.59past year
Oct 27, 2026 · Official close
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$655.85MFY 2025
$842.68M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$655,847,000reported
FY 20242024-12-31$724,343,000reported
FY 20232023-12-31$770,885,000reported
FY 20222022-12-31$842,681,000reported
FY 20212021-12-31$821,682,000reported
FY 20202020-12-31$476,251,000reported
FY 20192019-12-31$128,534,000reported

Segments

Revenue by Segments, FY2024 to FY2025FY2024Retail · FY2024 · $471.75MWholesale · FY2024 · $252.59MFY2025Retail · FY2025 · $433.08MWholesale · FY2025 · $222.77M
LineFY2025ShareChange
Retail$433.08M66%−8.2%
Wholesale$222.77M34%−11.8%
Total$655.85M

From the 40-F filed Mar 6, 2026CRLBF

Medicinal chemicals & botanical products

Cresco Labs Inc. is the 5th largest of the 41 covered companies the SEC files under this code, by revenue. SIC 2833

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Cresco Labs Inc. · CIK 1832928 · Engraved from SEC EDGAR